Skip to content
Home/Companies/Biotech/Alphalyse

Alphalyse

Biotech·Denmark·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Alphalyse?

Alphalyse is currently owned by Fidelio Capital through Fidelio Capital (2010 vintage), since 2025.

Hand-verified · updated 2026-08-17

Fidelio Capital
Investor
Fidelio Capital
Fidelio Capital · 2010 · Buyout

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Fidelio Capital

Other portfolio companies in the same fund.

Audria
Active
PropTechSweden· 2025
Greenfood
Active
ConsumerSweden· 2025
Keyto
Active
ConsumerSweden· 2021
Lyko
Active
E-commerceSweden· 2021
iBinder
Active
SaaSSweden· 2019
Odevo
Active
Real EstateSweden· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Alphalyse

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alphalyse?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alphalyse.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue